HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs.

AbstractPURPOSE:
Two different monoclonal antibody-targeted HPMA copolymer-doxorubicin conjugates, classic and starlike, were synthesized to be used for site-specific cancer therapy. The anti-mouse Thy-1.2 (IgG3) and two anti-human CD71/A (IgG1) and CD71/B (IgG2a) monoclonal antibodies were used as targeting structures.
METHODS:
Their binding and cytotoxic activity in vitro, body distribution, and anticancer activity in vivo were evaluated.
RESULTS:
The results of flow cytometric analysis showed comparable binding of classic and starlike conjugates to the target cells. The in vitro cytotoxic effect was 10-fold higher if cancer cells were exposed to the starlike conjugate compared to the classic one. Biodistribution studies showed that the starlike conjugate remained in a relatively high concentration in blood, whereas the classic conjugate was found in a 6.5-times lower amount. In contrast to the low antitumor activity of free doxorubicin and nontargeted HPMA copolymer-doxorubicin conjugate, both anti-Thy-1.2 targeted conjugates (classic and starlike) cured all mice bearing T-cell lymphoma EL4. On the other hand, starlike conjugates containing anti-CD71/A or anti-CD71/B monoclonals as targeting structures were more effective against human colorectal cancer SW 620 than the classic one.
CONCLUSIONS:
We have shown that the starlike conjugates are more effective systems for targeted drug delivery and cancer treatment than classic conjugates.
AuthorsMarkéta Jelínková, Jirí Strohalm, Tomás Etrych, Karel Ulbrich, Blanka Ríhová
JournalPharmaceutical research (Pharm Res) Vol. 20 Issue 10 Pg. 1558-64 (Oct 2003) ISSN: 0724-8741 [Print] United States
PMID14620507 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibiotics, Antineoplastic
  • Antibodies, Monoclonal
  • Methacrylates
  • Prodrugs
  • Doxorubicin
  • hydroxypropyl methacrylate
Topics
  • Animals
  • Antibiotics, Antineoplastic (chemistry, pharmacokinetics, pharmacology)
  • Antibodies, Monoclonal (chemistry, metabolism)
  • Cell Division (drug effects)
  • Cell Line, Tumor
  • Colorectal Neoplasms (drug therapy)
  • Doxorubicin (chemistry, pharmacokinetics, pharmacology)
  • Humans
  • In Vitro Techniques
  • Lymphoma, T-Cell (drug therapy)
  • Methacrylates (chemistry, pharmacology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Molecular Structure
  • Neoplasm Transplantation
  • Prodrugs (chemistry, pharmacology)
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: